Related Experiment Video

Updated: Jun 14, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic

Udaya S Tantry1, Kevin P Bliden, Thomas A Suarez

  • 1Sinai Center for Thrombosis Research, Baltimore, Maryland 21215, USA.

Platelets
|April 10, 2010
PubMed

Insights

Platelet reactivity, hypercoagulability, and inflammation increase with coronary artery disease (CAD) acuity. Unstable angina shows significantly heightened markers, indicating a prothrombotic state.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Clinical Pathology

Background:

  • Coronary artery disease (CAD) acuity is associated with complex pathophysiological changes.
  • Understanding the interplay of platelet function, coagulation, and inflammation is crucial for managing CAD progression.

Purpose of the Study:

  • To investigate the relationship between platelet reactivity, hypercoagulability, and inflammation across different stages of CAD acuity.
  • To assess specific biomarkers in asymptomatic stable CAD, stable angina, and unstable angina patients.

Main Methods:

  • Thrombelastography was used to measure thrombin-induced platelet-fibrin clot strength (MA) and time to clot formation (R).
  • Flow cytometry assessed activated GPIIb/IIIa receptor expression.
  • Fluorokine multianalyte profiling assays measured C-reactive protein (CRP) and other prothrombotic factors.

Main Results:

  • A significant stepwise increase in MA was observed from asymptomatic stable CAD to stable angina and unstable angina (p < 0.001).
  • MA showed the strongest correlation with other prothrombotic markers (p ≤ 0.02) and CRP (p < 0.001) across all CAD acuity levels.
  • All measured biomarkers generally increased from stable to unstable disease states.

Conclusions:

  • Heightened platelet function, hypercoagulability, and inflammation characterize unstable cardiovascular disease requiring intervention.
  • These findings suggest a distinct prothrombotic state associated with clinical destabilization in CAD.
  • Further research is needed to elucidate the primary mechanisms linking these processes.

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...